CN Patent

CN121265579A — 秋水仙碱在制备tbk1磷酸化促进剂中的应用

Assigned to Union Hospital Tongji Medical College Huazhong University of Science and Technology · Expires 2026-01-06 · 0y expired

What this patent protects

本发明涉及医疗药物技术领域，具体公开了秋水仙碱在制备‌TANK结合激酶1‌（TBK1）磷酸化促进剂中的应用。本发明创造性地发现秋水仙碱可以通过促进TBK1的磷酸化，从而达到治疗和/或预防特定疾病的效果，这和现有技术中普遍认为的TBK1磷酸化不利于特定疾病的治疗和/或预防是完全不同的创新研究成果。

USPTO Abstract

本发明涉及医疗药物技术领域，具体公开了秋水仙碱在制备‌TANK结合激酶1‌（TBK1）磷酸化促进剂中的应用。本发明创造性地发现秋水仙碱可以通过促进TBK1的磷酸化，从而达到治疗和/或预防特定疾病的效果，这和现有技术中普遍认为的TBK1磷酸化不利于特定疾病的治疗和/或预防是完全不同的创新研究成果。

Drugs covered by this patent

Patent Metadata

Patent number
CN121265579A
Jurisdiction
CN
Classification
—
Expires
2026-01-06
Drug substance claim
No
Drug product claim
No
Assignee
Union Hospital Tongji Medical College Huazhong University of Science and Technology
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.